Showing 2040 results
-
Story /Novartis researchers are learning how a novel approach to immunotherapy could help treat cancer.
-
Story /Novartis is investing in a novel type of medicine to reduce the risk of heart disease.
-
Story /Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.
-
Press release /New collaborations aim to reduce the burden of sickle cell disease (SCD) in East Africa and improve access to high quality care Program continues progress in Ghana with more than 2000 patients…
-
Press release /Global headquarters to be co-located in Geneva alongside Alcon's Europe, Middle East and Africa regional office The listed Alcon company will be incorporated in Fribourg, where Alcon already has…
-
Ad hoc release /Bertrand Bodson, Chief Digital Officer, appointed to the Executive Committee of Novartis (ECN) Steffen Lang, Global Head Novartis Technical Operations, appointed to the ECN Shannon Klinger…
-
Ad hoc release /Bertrand Bodson, Chief Digital Officer, wird in die Geschäftsleitung von Novartis berufen Steffen Lang, Global Head Novartis Technical Operations, wird in die Geschäftsleitung von Novartis berufen…
-
Story /Novartis’ Don Ganem tapped as a scientific advisor for the Chan Zuckerberg Biohub
-
Featured News /
The Corporate Reputation of Pharma 2019 global report reflects the findings of a survey conducted by PatientView with patient organizations worldwide.
-
Story /An antibody that boosts muscle mass could mean independence for the frail and elderly. Learn how Novartis research aims to improve healthy aging.